Overview

Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione

Status:
Completed

Trial end date:
2002-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of Amaryl when added to Metformin and Thiazolidinedione (TZD) in non-insulin dependent diabetes mellitus (NIDDM) patients.

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

2,4-thiazolidinedione
Glimepiride
Metformin